Viewing Study NCT05124561


Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2025-12-29 @ 6:32 AM
Study NCT ID: NCT05124561
Status: WITHDRAWN
Last Update Posted: 2023-06-18
First Post: 2021-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Sponsor: CanSino Biologics Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CS-CTP-AD5NCOV-IH-Ⅲ
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View